Xyosted 50 MG/0.5 ML auto-INJ 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FVKR3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,091
Award facts
- Contract value 100% obligated
- $1,090.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,090.66 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Xyosted 50 mg/0.5 mL auto-injector cartridges. The contract is a firm fixed price delivery order with an ultimate completion date of September 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made without a set-aside designation, indicating competitive selection among qualified vendors. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. As the prime contractor under the SPE2DX IDC, the company supplies a comprehensive range of pharmaceutical products and medical supplies to support Defense Health Agency operations and other government healthcare systems worldwide. Xyosted is a testosterone replacement therapy administered via auto-injection, reflecting the company's role in providing specialized pharmaceutical commodities across multiple therapeutic domains. The delivery order represents a routine replenishment transaction under this large-scale pharmaceutical support vehicle that enables flexible sourcing of medical supplies for military healthcare programs.
Quick answers
Who was awarded contract SPE2DB25FVKR3?
SPE2DB25FVKR3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FVKR3 worth?
The government has obligated $1,091 on SPE2DB25FVKR3.
Is contract SPE2DB25FVKR3 an order under another contract?
Yes. SPE2DB25FVKR3 is a delivery order under SPE2DB22D1202, an indefinite delivery contract.
Was contract SPE2DB25FVKR3 competed?
The extent of competition for SPE2DB25FVKR3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award